Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: SADIF-Investment Analytics, S.A.
|
$115.00
|
|
Provider: SADIF-Investment Analytics, S.A.
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
ilshinbiobase Co., Ltd. Announces Cancellation of Contract with Korea-based Company
ilShinbiobase Co., Ltd. announced that its contract with a Korea-based company to construct cutting edge intelligence freezing facilities, initially announced on May 16, 2011, has been cancelled due to the requirement of the other side.
Latest Developments for ilShinBioBase Co Ltd
Latest Key Developments in Biotechnology
- Oramed Pharmaceuticals Inc Receives FDA Clearance To Initiate Oral Insulin Trials In U.S.
- Cordlife Group Ltd Announces Proposed Acquisition Of CS Cell Technologies Pte. Ltd, Cordlife Stem Cell Technology Limited And Certain Assets Of P.T. Cordlife Indonesia From Cordlife Limited
- Stemline Therapeutics Inc Prices $60 Million Public Offering Of Common Stock
- Ambit Biosciences Corp Announces Pricing Of Initial Public Offering
- Share this
- Link this
- Digg this
Follow Reuters